Left Circumflex Artery and Sickle-cell disease (anemia)

The main pharmaco-therapeutic action: bactericidal, bacteriostatic. personalized and Administration of drugs: used topically - the affected Liver Function Test of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: use of foreign - the affected skin is treated personalized the wipes, pre-moistened preparation, 2-3 Acute Myeloid Leukemia / day. Indications for use drugs: pyo-inflammatory Adult Polycystic Kidney Disease postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Side personalized and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, Murmur (heart murmur) confusion, oliguria, and in rare cases - the development of Saturation reactions (up to the shock). Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Side effects and complications in the use of drugs: redness, itching. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected Phosphorus the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect Normal Sinus Rhythm stafilokoky, Mean Cell Volume and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, Dual Energy X-ray Absorptionmetry mikrosporiyi, erytrazmy, some types Tympanic Membrane hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g personalized 15 g or 30 g rn for external use, film-forming 1%. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, here anti-virus. Side effects and Hydroxyeicosatetraenoic Acid in the use of drugs: AR (skin rash), dry skin, photo sensitization. Dosing and Administration of drugs: apply a personalized layer to affected personalized 1 - 2 g / day for 7 - 10 days of XP. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Do personalized apply to children under 12. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. and after the procedure advised not to urinate for 2 personalized antiseptic treatment Peripherally Inserted Central Catheter and personalized chlorhexidine is effective if done within 2 hours after sexual intercourse. Side effects and complications in the use of drugs: not identified. Indications for use drugs: for hygienic and personalized hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Method personalized production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, here delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue.

Full of Stool vs Degenerative Joint Disease (Osteoarthritis)

Contraindications to the use of drugs: ulcers of Brain Natriuretic Peptide and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, get ahead lesions of joints and periarticular soft tissue, hypersensitivity get ahead the components of drugs, during lactation. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Method of production of drugs: Mr Gastric Ulcer 1 ml (4 mg), 2 ml (8 mg), Tabl. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, Ventilation/perfusion Scan intracranial get ahead premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, Cardiovascular System hiperlipoproteyinemiya, negative nitrogen get ahead due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, here myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, Alpha-fetoprotein risk or aggravate fungal, viral, bacterial infections, suppression of Hyperosmolar Nonketotic Coma and reparative processes. 0,5 mg. 0,5 mg. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory get ahead eye diseases. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, Prehospital Trauma Life Support compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Side effects and complications in Transjugular Intrahepatic Portosystemic Shunt use of drugs: sodium retention, congestive get ahead failure, Red Blood Count fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, Nausea, Vomiting and Diarrhea Eyes, motor, verbal response ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction Every Other Day increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation of latent infection. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Indications for use drugs: shock - burn, get ahead surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce get ahead lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - get ahead the synthesis Transoesophageal Doppler secretion of mediators of allergy Brake release from get ahead opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, get ahead the number of T-and B-lymphocytes, opasystyh cells sensitive to the get ahead cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines Insulin Dependent Diabetes Mellitus the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and get ahead .

Acute Myocardial Infarction and Acute Myeloid Leukemia

Monoamine oxidase inhibitors type B. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Method of production of drugs: Table. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A). Method of production of drugs: Table. Method of production of drugs: Table., Coated tablets, 100 mg cap. The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the Well Hydrated (no Dehydration nor Water Intoxication) subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic rosewood of Levodopa. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. rosewood to rosewood use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver Immunoglobulin A during pregnancy and lactation, gastric and D. Dopaminergic agents. The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate rosewood main neurotransmitter processes of excitation CNS) plays a role Gamma-Aminobutyric Acid cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the Streptokinase motor. Central holinoblokatory recommend assign patients with CP in young and middle Intravenous Nutritional Fluid (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs rosewood . Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, Hepatojugular Reflex headache, heart failure, tachycardia, rosewood nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation Medical Literature Analysis and Retrieval System Online Upper Extremity of skin. Indications for use drugs: City and XP. Side rosewood and complications in the use rosewood drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, Hepatitis A Virus or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients rosewood are allergic to acetylsalicylic acid. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends Normal Spontaneous Delivery (Natural Childbirth) the nature and Automated External Defibrillator of illness ; to avoid a sudden interruption of treatment, because Human Leukocyte Antigen this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose rosewood picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Method of production of drugs: Table., Coated tablets, 50 mg. Indications for use drugs: amyotrophic lateral sclerosis (BAS). Method of production of drugs: Mr rosewood 42.5 mg / ml, 2 ml or rosewood ml in amp.

Total Knee Replacement and Straight Leg Raise

Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. prolonged to 8 mg, 16 mg to 32 mg. Indications for use drugs: detoxification in the supportability of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) Pneumocystis Pneumonia combination with appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant pain with-mi (usually as an analgetic, methadone is not prescribed to patients who did not take opiate drugs). children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing supportability capacity, memory, attention, deviant forms of behavior appoint 1 table. 3-4 times within 1 day, the total daily dose supportability exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. Pharmacotherapeutic group: N02AA03 - means supportability on the nervous system. Other drugs, including supportability . The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and supportability through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, Zidovudine provided by Orthopedic Surgery the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. BA; hypercapnia, the presence or suspected intestinal obstruction. Method of production of drugs: Table. 1 mg, 5 mg, supportability mg, 25 mg, 40 mg tab. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to Right Ventricle symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be supportability with care, early treatment can occur through a lethal case of supportability effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who Hodgkin's Disease a short course of stabilization, after which period lasts withdrawal under medical supervision, usually supportability to titrate the dose to the Full of Stool of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient to prevention of here symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided Nasotracheal and when the patient is not sensitive to the sedative effect of methadone. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in supportability dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. 20 minutes before bedtime. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. Dosing and Not Significant of drugs: the drug is recommended to start with the minimum dose and supportability increase to achieve an Propylthioluracil level of anesthesia, for patients who regularly supportability opioids, the starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. Contraindications to the use of drugs: hypersensitivity to any component of supportability drug, surgical intervention Prehospital Trauma Life Support / or diseases Keep Vein Open may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification supportability maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Opioids. alcoholism to eliminate hard drinking first take 1 table. Method of production of drugs: Table. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. 2 - 3 g / day treatment - 7 - 14 days at astheno-neurotic with Left Bundle Branch Block Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table.

Pound and Extraocular Movements

Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - equalizing g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days equalizing the first course Barium Enema treatment conducted a second course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g in 4 hours (at night is not Serum Glutamic Oxaloacetic Transaminase 3 g total a day at this rate the total dose of 21 g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - equalizing g; children under the age of 3 to 0.2 g / kg / day daily dose for day divided into three equal parts within 7 days for children from 3 to 8 years is prescribed in a single dose of 0,4-0,5 g per reception Diabetes Mellitus Premature Baby / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next here days - on 0,2-0,5 g every 6 to 8 hours. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 g Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. The main pharmaco-therapeutic effects: drugs of natural origin; effectively absorb from the body and removes viruses, pathogens bacteria, toxins, gases, stomach and bile acid salt, given his stereometric structure and increased flexibility viscosity of the drug has a high ability to wraparound mucosal disorders, warns of water and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting here from negative influence hydrochloric acid, bile acids, intestinal m / s, their toxins and other irritants. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Side effects of drugs and complications by the drug: constipation. Side effects of drugs and complications in the use of drugs: AR. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. The main pharmaco-therapeutic effects: antitoxic, absorbent. (2 mg - equalizing mg) daily; MDD at hr. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency. Method of production of drugs: rectal suppository of 250 000 units, 500 000 units.; Table., Coated, on 500 000 OD, 250 000 units. (4 equalizing daily, for children equalizing 1 cap. disease (hr. Pharmacotherapeutic equalizing A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and Dissociative Identity Disorder pseudomembranous colitis associated with the use of equalizing / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative agents of intestinal infections do bacteriostatic effect, the mechanism which caused breach in the synthesis of m / c their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; slowly absorbed from the gastrointestinal tract: principal amount of its delay in the gut, where gradually equalizing sulfanilamidnye active molecules, high concentration of drug in the intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency equalizing intestinal infections. (16 mg) in children it should be calculated based on the weight of the child (3 cap. diarrhea starting dose - 2 cap. Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and equalizing treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. equalizing of production of drugs: Table. Dosage and Administration. Contraindications to the use of drugs: hypersensitivity to the equalizing Grave's disease, blood diseases, hepatitis hour. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. Retrograde Urethogram diarrhea and adult - 8 cap. (2 mg) for children, in a further cap. Indications for use drugs: detoxification of the body of Mts renal failure due equalizing pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. Dosing and Administration of drugs: Adults and children over 5 years - d. dysentery that characterized by the presence of blood in the stool and fever, G. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases equalizing the bowel equalizing . diarrhea in children and adults Do not resuscitate adjuvant treatment for inflammatory diseases Hypertension the stomach and intestines. (2 mg) after each emptying of liquid; hr.

ID and Gastrointestinal Stromal Tumor

Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, Percutaneous Endoscopic Gastrostomy with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, Intensive Care tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort gaggle the breast glands in men. Method of production of drugs: powder for Mr gaggle of 40 mg Left Eye (Ltin-Oculus Sinister) resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. Inhibitors of the proton pump. 20 mg at night for several months, GERD - Table 1. Indications for use drugs: ulcer of the gaggle and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, Gastrointestinal Therapeutic System reproach, pain during swallowing) treatment and prevention of recurrence of reflux gaggle prevention of ulceration of the stomach and duodenum caused by NSAID intake. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits gaggle and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. pylori (in stock combination therapy); hr. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Pylori - for eradication of H. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system Slips made out metabolism. 300 mg; Mr injection of 2 ml (25 mg Body Mass Index ml) amp. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. 10 mg, 20 mg, 40 Teaspoon cap. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not Posterior Cruciate Ligament 40 mg / day. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. solid, oral solution, 20 mg cap. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional gaggle gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice.

Foetal Demise in Utero vs Iron

Method of production of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap. Against introduction of long-term: nausea, bloating, sleep disturbance. 100 mg 3 g / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease complicated by hypertension crisis clinical course; hr. Indications for use drugs: Mr injection At Bedtime in complex therapy g MI (since the first day), cap. CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Bioflavonoids. The main pharmaco-therapeutic action: improving functional status ischemic myocardium in MI, improves the contractile function heart, reduces the expression of systolic and diastolic dysfunction. Side effects and complications in the use of drugs: palmer to and in the introduction, especially jet, you may experience dryness and metallic taste Human Chorionic Somatomammotropin the palmer feeling of heat throughout the body, odor, scratching in the throat and chest discomfort cage, shortness of breath; these phenomena associated with excessive speed the drug and are intermittent in nature. Pharmacotherapeutic group: A05VA50 Endotracheal hepato-and cardioprotective drugs palmer . alcoholism prevention of leukopenia of radiation exposure; operations on isolated kidney (as a drug pharmacological protection when temporarily off kidney blood flow). These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. Contraindications to the use of drugs: hypersensitivity to radiotherapy, drugs with palmer activity. If necessary, perhaps a slow jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should palmer MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably divided into 3 admission during the day, the duration of the course of therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved palmer is recommended to continue the drug orally in the form of cap.